BIOventures_logoR2.jpg
  • HOME

  • NEWS

  • ABOUT

    • Company
    • Mission
    • Research Team
  • TECHNOLOGY

  • PATENTS AND PUBLICATIONS

  • GRANTS

  • WE CARE

  • CONTACT

  • More

    Use tab to navigate through the menu items.

    Recent news

    Grant from The National Centre for Research and Development

    • Oct 2, 2021

    Bacteriophages of Thermophilic ‘Bacillus Group’Bacteria—A Review

    • Jul 2, 2021

    Positive initial animal trials of the recombinant anti-SARS-CoV-2 vaccine

    • Jun 21, 2021

    Archived news

    • October 2021 (1) 1 post
    • July 2021 (1) 1 post
    • June 2021 (1) 1 post
    • April 2021 (1) 1 post
    • March 2021 (1) 1 post
    • December 2020 (1) 1 post
    • November 2020 (1) 1 post
    • August 2020 (3) 3 posts
    • July 2020 (2) 2 posts
    • June 2020 (1) 1 post
    • May 2020 (1) 1 post
    • April 2020 (1) 1 post
    • March 2020 (1) 1 post
    • December 2019 (1) 1 post
    • November 2019 (2) 2 posts
    • August 2018 (1) 1 post
    • April 2018 (1) 1 post
    • December 2017 (1) 1 post
    • November 2017 (1) 1 post
    • October 2017 (1) 1 post
    • August 2017 (1) 1 post
    • July 2017 (2) 2 posts
    • January 2017 (1) 1 post
    • November 2016 (1) 1 post
    • February 2016 (2) 2 posts
    • October 2015 (2) 2 posts
    • June 2015 (1) 1 post
    • April 2015 (1) 1 post
    • March 2015 (1) 1 post
    • October 2014 (1) 1 post
    • July 2014 (1) 1 post
    • January 2014 (1) 1 post
    • December 2013 (1) 1 post
    • August 2013 (1) 1 post
    • June 2013 (1) 1 post
    • October 2012 (1) 1 post
    • April 2012 (1) 1 post
    • March 2012 (1) 1 post
    • November 2011 (1) 1 post
    New scientific publication
    • Apr 6, 2018

    New scientific publication

    New scientific publication, defining a new bacteriophage genus TP84 virus. The paper describes monographic work on TP-84 bacteriophage genomics, bioinformatics and proteomics analysis leading to the construction of a new thermostable, nanobiocarrier for bioactive molecules. Moreover, this work is important from basic research stand point. Because the genome sequence shows essentially no similarity to any previously characterised bacteriophage, TP-84 should be considered a new
    MaaS™ - MOLECULES AS A SERVICE

    © BioVentures Institute 2020

    • HOME

    • NEWS

    • ABOUT

      • Company
      • Mission
      • Research Team
    • TECHNOLOGY

    • PATENTS AND PUBLICATIONS

    • GRANTS

    • WE CARE

    • CONTACT

    • More

      Use tab to navigate through the menu items.

      TERMS

      PRIVACY